| Date Filed | Type | Description |
| 10/12/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 10/02/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 07/27/2023 |
SC 13G
| EcoR1 Capital, LLC reports a 16.9% stake in Mersana Therapeutics, Inc. |
| 07/18/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 06/16/2023 |
SC 13G/A
| EcoR1 Capital, LLC reports a 6.8% stake in Revolution Medicines, Inc. |
| 06/07/2023 |
SC 13G
| EcoR1 Capital, LLC reports a 9.9% stake in Galapagos NV |
| 02/14/2023 |
SC 13G/A
| EcoR1 Capital, LLC reports a 6.7% stake in Galapagos NV |
| 02/14/2023 |
SC 13G/A
| EcoR1 Capital, LLC reports a 0% stake in Avidity Biosciences, Inc. |
| 02/14/2023 |
SC 13G/A
| EcoR1 Capital, LLC reports a 3% stake in 2seventy bio, Inc. |
| 02/14/2023 |
SC 13G/A
| EcoR1 Capital, LLC reports a 9.1% stake in Hookipa Pharma Inc. |
| 02/14/2023 |
SC 13G
| EcoR1 Capital, LLC reports a 10% stake in Tempest Therapeutics Inc. |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2023 |
SC 13G/A
| EcoR1 Capital, LLC reports a 8.7% stake in Ovid Therapeutics Inc. |
| 02/10/2023 |
SC 13G/A
| EcoR1 Capital, LLC reports a 0% stake in Akouos, Inc. |
| 02/10/2023 |
SC 13G/A
| EcoR1 Capital, LLC reports a 7.6% stake in ORIC Pharmaceuticals, Inc. |
| 02/10/2023 |
SC 13G/A
| EcoR1 Capital, LLC reports a 9.9% stake in Kura Oncology, Inc. |
| 02/10/2023 |
SC 13G/A
| EcoR1 Capital, LLC reports a 0% stake in Gritstone bio, Inc. |
| 02/10/2023 |
SC 13G/A
| EcoR1 Capital, LLC reports a 7.4% stake in Atea Pharmaceuticals, Inc. |
| 02/10/2023 |
SC 13G/A
| EcoR1 Capital, LLC reports a 4.9% stake in Alector, Inc. |
| 01/23/2023 |
SC 13G
| EcoR1 Capital, LLC reports a 5% stake in Revolution Medicines, Inc. |
| 01/13/2023 |
SC 13G/A
| EcoR1 Capital, LLC reports a 10% stake in Voyager Therapeutics, Inc. |
| 01/09/2023 |
SC 13G/A
| EcoR1 Capital, LLC reports a 14.7% stake in Graphite Bio, Inc. |
| 12/22/2022 |
SC 13G
| EcoR1 Capital, LLC reports a 8.3% stake in Adicet Bio, Inc. |
| 11/23/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 11/18/2022 |
SC 13G
| EcoR1 Capital, LLC reports a 9.8% stake in Graphite Bio, Inc. |
| 11/14/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 11/01/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 10/28/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 10/28/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 09/26/2022 |
SC 13G
| EcoR1 Capital, LLC reports a 5.5% stake in Edgewise Therapeutics, Inc. |
| 09/19/2022 |
SC 13G
| EcoR1 Capital, LLC reports a 5.5% stake in Springworks Therapeutics, Inc. |
|